Google has yet again filed another patent for its innovative device that allows needle-free blood drawing. This is another contribution from Google’s medtech and healthcare sector. The patent filed to the US Patent and Trademark Office (USPTO) describes the device as "A system for needle-free drawing of blood is disclosed. A device can include an evacuated negative-pressure barrel with a membrane sealing an aperture at a distal end, and a housing affixed to a proximal end.". The patent went further to state that “In a typical scenario, a person's blood is drawn and either sent to a lab or input into a handheld testing device, such as a glucose meter, where one or more tests are performed to measure various analyze levels and parameters in the blood,”.
On an interview with The Verge a Google spokesperson stated, "We hold patents on a variety of ideas – some of those ideas later mature into real products or services, some don't....Prospective product announcements should not necessarily be inferred from our patents.” Therefore it can be inferred that the product may or may not eventually exist.
Google life sciences unit, has recently named the device Verily, claiming that the name will stand unique in the fast-growing medical technology sector. Following the name change Google has moved on to seeking patent for the name Alphabet, a publicly traded company that holds Google's core search and web advertising business, maps, YouTube and its other projects such as the driverless cars called the "moon shot".
The new device Verily claims, "to bring together technology and life sciences to uncover new truths about health and disease." As stated, this device is further associated with other projects such as developing more efficient contact lenses partnering with the Swiss drug company Novartis. The company has also taken up a year-long plan into a researching program called the Baseline study that seeks to locate characteristics of an ideal healthy person, and the transitional changes that they undergo while falling ill.